HOUSTON, May 1, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) and Encysive (UK) Limited, the Company’s European operations, today announced plans to participate in three European medical conferences during 2007. The Company will also provide educational funding to two rheumatology-related organizations in order to further advance its commitment to scientific research and medical education for pulmonary arterial hypertension (PAH) and related diseases.
